Displaying 1261 - 1280 of 2316
FTC Preserves Competition in Merger of Enbridge Inc. and Spectra Energy Corp
FTC Requests Public Comment on Application from SuperValu Inc. to Sell Supermarket Divested by Safeway and Albertsons
FTC Approves Final Order with Parent Company of Bausch + Lomb
Valeant Pharmaceuticals International, Inc., In the Matter of
Valeant Pharmaceuticals, the parent of Bausch + Lomb, agreed to sell Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon reduced competition for the sale of FDA-approved buttons used for three types of gas permeable, or GP, lenses: orthokeratology lenses, worn to reshape the cornea; large-diameter scleral lenses, which cover the white of the eye and are used after eye surgery, for corneal transplants, and to treat eye disease; and general vision correction lenses. Valeant will sell Paragon in its entirety to a newly created entity, Paragon Companies LLC, headed by the former president of Paragon, Joe Sicari. Under the settlement, Paragon Companies also will acquire the assets of Pelican Products LLC – a contact lens packaging company that Valeant acquired after its purchase of Paragon – that is the only producer of FDA-approved vials used for shipping some GP lenses.
FTC Charges That Shire ViroPharma Inc. Abused Government Processes Through Serial, Sham Petitioning to Delay Generics and Maintain its Monopoly over Vancocin HCl Capsules
FTC Releases Staff Study Examining Commission Merger Remedies between 2006 and 2012
Endo Pharmaceuticals Inc. Agrees to Abandon Anticompetitive Pay-for-Delay Agreements to Settle FTC Charges; FTC Refiles Suits Against Generic Defendants
The FTC's Merger Remedies 2006-2012: A Report of the Bureaus of Competition and Economics
FTC Announces Annual Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates
Puerto Rico Ophthalmologist Group Settles FTC Charges that Members Agreed to an Illegal Boycott of Health Plan
Mallinckrodt Will Pay $100 Million to Settle FTC, State Charges It Illegally Maintained its Monopoly of Specialty Drug Used to Treat Infants
FTC Charges Qualcomm With Monopolizing Key Semiconductor Device Used in Cell Phones
In Two Separate Actions, FTC Charges Investors with Violations of U.S. Premerger Notification Requirements
FTC Staff Provides Supplemental Public Comment in Virginia Opposing Health Systems’ Cooperative Agreement Application
FTC and DOJ Issue Updated Antitrust Guidelines for the Licensing of Intellectual Property
FTC Approves Final Order Preserving Competition for Certain Physician Services in St. Cloud, MN
FTC Staff Provides Supplemental Public Comment in Tennessee Opposing Health Systems’ Certificate of Public Advantage Application
FTC Announces Workshop on Hearing Health and Technology
Displaying 1261 - 1280 of 2316